DOSSIERS / INNOVATIVE CONCEPTS IN DRUG DEVELOPMENT
← SearchExport PDF
Company dossier

INNOVATIVE CONCEPTS IN DRUG DEVELOPMENT

FRANCE · COMPANY · INCORPORATED 2015-02-27
KYBE ID: FR-498607449 · 498607449 · 2 sources
RISK SCORE18LOW RISK

Key facts

dissolved
INNOVATIVE CONCEPTS IN DRUG DEVELOPMENT
fr_insee
498607449
fr_insee
dissolved
fr_insee
Simplified joint-stock company (SAS)
fr_insee
2015-02-27
fr_insee
2022-07-28
fr_insee
800 AV DU CHATEAU DE JOUQUES, 13420 GEMENOS
fr_insee
72.11Z
fr_insee
€149,525
fr_insee

Ownership structure

1 entities

No ownership links on record for this entity.

Companies at this address

26 total

People with significant control

1 people
NameRoleFromSource
NATHALIE COMPAGNONEPrésident du conseil d'administrationFrance registry

Risk signals

2 matched
low

Clustered address

Address shared by 26 companies

medium

Court-ordered liquidation

Liquidation on the official insolvency record (Companies House / BODACC) — opened 2019-01-10

Risk journey — why 18?

2 signals
+12
Court-ordered liquidation
+6
Clustered address
Composite risk score18/100

Insolvency timeline

6 events
Jugement d'ouverture d'une procédure de redressement judiciaire
Jugement de conversion en liquidation judiciaire
Liste des créances nées après le jugement d'ouverture d'une procédure de redressement judiciaire
Dépôt de l'état des créances
Jugement de clôture pour insuffisance d'actif
Dissolved / struck off